A variety of downstream signaling cascades can be triggered by nicotine through α7 nicotinic receptors, including the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways, resulting in the progression of cancer [40, 41]. This evidence concerns the gene MAP2K1 and cancer.